Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1964 1
1970 1
1973 1
1984 1
1986 1
1988 4
1989 3
1990 5
1991 2
1992 5
1993 1
1996 3
1997 2
1999 1
2000 1
2001 1
2002 5
2003 7
2004 9
2005 7
2006 7
2007 8
2008 9
2009 6
2010 5
2011 11
2012 10
2013 5
2015 3
2016 11
2017 11
2018 8
2019 8
2020 12
2021 7
2022 4
2023 7
2024 14
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Bhatt DL, et al. N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415628 Clinical Trial.
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes.
Godoy-Matos AF, Silva Júnior WS, Valerio CM. Godoy-Matos AF, et al. Among authors: valerio cm. Diabetol Metab Syndr. 2020 Jul 14;12:60. doi: 10.1186/s13098-020-00570-y. eCollection 2020. Diabetol Metab Syndr. 2020. PMID: 32684985 Free PMC article. Review.
Randomized trial of bilateral gene therapy injection for m.11778G>A MT-ND4 Leber optic neuropathy.
Newman NJ, Yu-Wai-Man P, Subramanian PS, Moster ML, Wang AG, Donahue SP, Leroy BP, Carelli V, Biousse V, Vignal-Clermont C, Sergott RC, Sadun AA, Rebolleda Fernández G, Chwalisz BK, Banik R, Bazin F, Roux M, Cox ED, Taiel M, Sahel JA; LHON REFLECT Study Group. Newman NJ, et al. Brain. 2023 Apr 19;146(4):1328-1341. doi: 10.1093/brain/awac421. Brain. 2023. PMID: 36350566 Free PMC article. Clinical Trial.
Diretriz brasileira baseada em evidências sobre prevenção de doenças cardiovasculares em pacientes com diabetes: posicionamento da Sociedade Brasileira de Diabetes (SBD), da Sociedade Brasileira de Cardiologia (SBC) e da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM).
Faludi AA, Izar MCO, Saraiva JFK, Bianco HT, Chacra APM, Bertoluci MC, Moreira RO, Turatti LAA, Bertolami A, Sulzbach ML, Schaan BD, Valerio CM, Bertolami MC, Malachias MVB, Vencio S, Betti RTB, Fonseca FAH, Salles JEN, Hohl A. Faludi AA, et al. Among authors: valerio cm. Arq Bras Cardiol. 2017 Dec;109(6 Suppl 1):1-31. doi: 10.5935/abc.20170188. Arq Bras Cardiol. 2017. PMID: 29489927 Free article. Portuguese. No abstract available.
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes.
Godoy-Matos AF, Valério CM, Silva Júnior WS, de Araujo-Neto JM, Bertoluci MC. Godoy-Matos AF, et al. Among authors: valerio cm. Diabetol Metab Syndr. 2024 Jan 19;16(1):23. doi: 10.1186/s13098-024-01259-2. Diabetol Metab Syndr. 2024. PMID: 38238868 Free PMC article. Review.
Editorial: Plant RNA Biology.
Szakonyi D, Confraria A, Valerio C, Duque P, Staiger D. Szakonyi D, et al. Among authors: valerio c. Front Plant Sci. 2019 Jul 9;10:887. doi: 10.3389/fpls.2019.00887. eCollection 2019. Front Plant Sci. 2019. PMID: 31338103 Free PMC article. No abstract available.
IVF in Costa Rica.
Valerio C, Vargas K, Raventós H. Valerio C, et al. JBRA Assist Reprod. 2017 Dec 1;21(4):366-369. doi: 10.5935/1518-0557.20170060. JBRA Assist Reprod. 2017. PMID: 28985042 Free PMC article. Review.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
191 results